Encompass Health Corp (EHC) Q1 2026 Earnings Call Transcript

Why It Matters

The results underscore Encompass Health’s ability to grow revenue and profitability while expanding its home‑health footprint, positioning it to capture rising demand for post‑acute care amid evolving Medicare reimbursement rules.

Key Takeaways

• Revenue rose 7.5% to $1.124 billion.
• Adjusted EBITDA increased 8.8% to $242.9 million.
• Alacare acquisition adds 46 locations, closing June.
• Clinical collaboration rate hit 36%, target 40%.
• CMS proposes CARE tool, potential 0.25% Medicare rate dip.

Pulse Analysis

Encompass Health’s first‑quarter performance reflects a broader trend of robust growth in the post‑acute care sector. Revenue growth was driven by a mix of volume gains, price increases across payer types, and the integration of recent acquisitions such as Camellia Healthcare. The company’s ability to generate $127.8 million of free cash flow allowed it to fund capacity additions, dividend payments, and share repurchases while maintaining a leverage ratio of 2.8x, signaling a solid balance‑sheet position that can support the upcoming $278.5 million Alacare deal.

Strategically, the Alacare acquisition expands Encompass Health’s home‑health and hospice footprint into three new overlap markets in Alabama, creating synergies through clinical collaboration. The firm reported a 36% collaboration rate, a 250‑basis‑point improvement year‑over‑year, and set a new target of 40% to enhance patient outcomes and reduce readmissions. This focus on integrated care aligns with the company’s three‑year sponsorship of the American Heart Association, which aims to shift stroke patients toward inpatient rehabilitation, further differentiating Encompass Health in a competitive market.

Regulatory changes loom large, with CMS proposing a CARE‑tool payment system that could flatten Medicare reimbursement by up to 0.25% and the rollout of the Patient‑Driven Groupings Model for home health, which shortens payment cycles and emphasizes clinical characteristics. Encompass Health is proactively adapting by refining its documentation, leveraging technology partners like MetaLogics and Homecare Homebase, and participating in the Review Choice Demonstration. These actions aim to mitigate financial impact, preserve margins, and capitalize on the aging U.S. population’s growing demand for high‑quality, cost‑effective post‑acute services.